-
Mashup Score: 3
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1SWOG Latin America Initiative News: Summer 2024 | SWOG - 10 day(s) ago
Our newsletter will help keep you informed of SLAI accomplishments and of opportunities to activate trials in our member sites in Mexico, Peru, Chile, Colombia, and Uruguay. This issue highlights a new approach to international collaboration in SWOG, SLAI opportunities for cancer care delivery research, and new collaboration in lymphoma, and shines a spotlight on SWOG member site in Uruguay the Universidad de la República. You can read the issue here.
Source: www.swog.orgCategories: General Medicine News, Oncologists1Tweet-
And catch the latest update on the @SWOG #LatinAmericaInitiative here: https://t.co/FuuO5lXWF1 With special gratitude to @incanMX, which was the first institution outside the U.S. to appear on our list of top accruers to SWOG trials (in 2021)! https://t.co/7FWeloH4Oh
-
-
Mashup Score: 2Not Your Father’s Oldsmobile’s Dashboard | SWOG - 12 day(s) ago
I’m proud to report that many of these dashboards are now built and have already been deployed to the SWOG website! They’re designed to
Source: www.swog.orgCategories: General Medicine News, Oncologists1Tweet-
Our @SWOGChair blog: Not Your Father’s Oldsmobile’s Dashboard We're building data dashboards to help @SWOG leaders & members better monitor progress, identify trends, and track performance. https://t.co/unALx9KGHv https://t.co/IRBIxq2rL5
-
-
Mashup Score: 7The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development - 12 day(s) ago
Abstract. Antibody–drug conjugates (ADC) represent one of the most rapidly expanding treatment modalities in oncology, with 11 ADCs approved by the FDA and more than 210 currently being tested in clinical trials. Spanning over 40 years, ADC clinical development has enhanced our understanding of the multifaceted mechanisms of action for this class of therapeutics. In this article, we discuss key insights into the toxicity, efficacy, stability, distribution, and fate of ADCs. Furthermore, we highlight ongoing challenges related to their clinical optimization, the development of rational sequencing strategies, and the identification of predictive biomarkers.Significance: The development and utilization of ADCs have allowed for relevant improvements in the prognosis of multiple cancer types. Concomitantly, the rise of ADCs in oncology has produced several challenges, including the prediction of their activity, their utilization in sequence, and minimization of their side effects, that stil
Source: aacrjournals.orgCategories: General Medicine News, Oncologists1Tweet-
Our #TranslationalMedicine link of the week, chosen by @SWOG's @recnac1 & Jimmy Rae, PhD: The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development in Cancer Discovery; 14:2089-2108, Nov 2024 https://t.co/yUMX7FK7Ha https://t.co/hbeMM0zokn
-
-
Mashup Score: 3
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Analysis of 30K+ pts comparing long-term risks of adverse effects from #prostatecancer treatment to untreated control group. Quantified risk needed for informed decisions on PSA screening & treatment. @JAMAOnc: https://t.co/ombh7qky2W Press release: https://t.co/Ms9XHixDkR #pcsm https://t.co/506Y7jMDuY
-
-
Mashup Score: 3
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Analysis of 30K+ pts comparing long-term risks of adverse effects from #prostatecancer treatment to untreated control group. Quantified risk needed for informed decisions on PSA screening & treatment. @JAMAOnc: https://t.co/ombh7qky2W Press release: https://t.co/Ms9XHixDkR #pcsm https://t.co/506Y7jMDuY
-
-
Mashup Score: 3
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Analysis of 30K+ pts comparing long-term risks of adverse effects from #prostatecancer treatment to untreated control group. Quantified risk needed for informed decisions on PSA screening & treatment. @JAMAOnc: https://t.co/ombh7qky2W Press release: https://t.co/Ms9XHixDkR #pcsm https://t.co/506Y7jMDuY
-
-
Mashup Score: 1SWOG Latin America Initiative News: Summer 2024 | SWOG - 15 day(s) ago
Our newsletter will help keep you informed of SLAI accomplishments and of opportunities to activate trials in our member sites in Mexico, Peru, Chile, Colombia, and Uruguay. This issue highlights a new approach to international collaboration in SWOG, SLAI opportunities for cancer care delivery research, and new collaboration in lymphoma, and shines a spotlight on SWOG member site in Uruguay the Universidad de la República. You can read the issue here.
Source: www.swog.orgCategories: General Medicine News, Oncologists1Tweet-
And catch the latest update on the @SWOG #LatinAmericaInitiative here: https://t.co/FuuO5lXWF1 With special gratitude to @incanMX, which was the first institution outside the U.S. to appear on our list of top accruers to SWOG trials (in 2021)! https://t.co/7FWeloH4Oh
-
-
Mashup Score: 3
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Analysis of 30K+ pts comparing long-term risks of adverse effects from #prostatecancer treatment to untreated control group. Quantified risk needed for informed decisions on PSA screening & treatment. @JAMAOnc: https://t.co/ombh7qky2W Press release: https://t.co/Ms9XHixDkR #pcsm https://t.co/506Y7jMDuY
-
-
Mashup Score: 3
This cohort study assesses the long-term adverse effects and complications of prostate cancer treatment in treated patients compared with a general population of older males.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Analysis of 30K+ pts comparing long-term risks of adverse effects from #prostatecancer treatment to untreated control group. Quantified risk needed for informed decisions on PSA screening & treatment. @JAMAOnc: https://t.co/ombh7qky2W Press release: https://t.co/Ms9XHixDkR #pcsm https://t.co/506Y7jMDuY
-
Analysis of 30K+ pts comparing long-term risks of adverse effects from #prostatecancer treatment to untreated control group. Quantified risk needed for informed decisions on PSA screening & treatment. @JAMAOnc: https://t.co/ombh7qky2W Press release: https://t.co/Ms9XHixDkR #pcsm https://t.co/506Y7jMDuY